Talking Deal Prices: CD&R sells PharMEDium for 20x EBITDA, high-yield credit shows strain

26 October 2015•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.